This study investigates advanced pancreatic cancer. It explores how a combination of investigational medications might work for patients who have already tried other treatments.
The study evaluates the safety and effectiveness of the medication combination. It looks at how well patients tolerate the treatment and how it affects their condition.
- Who can participate: Adults aged 18 to 80 with advanced pancreatic cancer that cannot be surgically removed or has spread can participate. They must have tried two previous treatments.
- Study details: Participants will take an investigational medication.